{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T13:52:50Z","timestamp":1789912370265,"version":"4.0.1"},"reference-count":54,"publisher":"Oxford University Press (OUP)","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2006,7,1]]},"DOI":"10.1093\/hmg\/ddl135","type":"journal-article","created":{"date-parts":[[2006,5,24]],"date-time":"2006-05-24T03:34:19Z","timestamp":1148441659000},"page":"2114-2124","source":"Crossref","is-referenced-by-count":63,"title":["Biologically active molecules that reduce polyglutamine aggregation and toxicity"],"prefix":"10.1093","volume":"15","author":[{"given":"Urvee A.","family":"Desai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Pallos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aye Aye K.","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent R.","family":"Stockwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie Michels","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Lawrence","family":"Marsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc I.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2006,5,23]]},"reference":[{"key":"key\n\t\t\t\t20171012173847_DDL135C1","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1136\/jnnp.45.11.1012","article-title":"X-linked recessive bulbospinal neuropathy: a report of ten cases","volume":"45","year":"1982","journal-title":"J. Neurol. Neurosrurg. Psychiat."},{"key":"key\n\t\t\t\t20171012173847_DDL135C2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1212\/WNL.18.7.671","article-title":"Progressive proximal spinal and bulbar muscular atrophy of late onset. A sex-linked recessive trait","volume":"18","year":"1968","journal-title":"Neurology"},{"key":"key\n\t\t\t\t20171012173847_DDL135C3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/352077a0","article-title":"Androgen receptor gene mutations in X-linked spinobulbar muscular atrophy","volume":"352","year":"1991","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012173847_DDL135C4","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/0092-8674(93)90585-E","article-title":"A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes","volume":"72","year":"1993","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171012173847_DDL135C5","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S0896-6273(00)81035-1","article-title":"Mutation of the E6-AP ubiquitin ligase reduces nuclear inclusion frequency while accelerating polyglutamine-induced pathology in SCA1 mice","volume":"24","year":"1999","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20171012173847_DDL135C6","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S0959-4388(99)00013-6","article-title":"Polyglutamine diseases: protein cleavage and aggregation","volume":"9","year":"1999","journal-title":"Curr. Opin. Neurobiol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C7","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1093\/hmg\/10.14.1511","article-title":"Over-expression of inducible HSP70 chaperone suppresses neuropathology and improves motor function in SCA1 mice","volume":"10","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C8","first-page":"747","article-title":"Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death","volume":"431","year":"2004","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012173847_DDL135C9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0092-8674(00)81781-X","article-title":"Ataxin-1 nuclear localization and aggregation: role in polyglutamine-induced disease in SCA1 transgenic mice","volume":"95","year":"1998","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171012173847_DDL135C10","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/hmg\/ddg151","article-title":"Polyglutamine protein aggregation and toxicity are linked to the cellular stress response","volume":"12","year":"2003","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C11","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/hmg\/10.26.3063","article-title":"Glucocorticoid modulation of androgen receptor nuclear aggregation and cellular toxicity is associated with distinct forms of soluble expanded polyglutamine protein","volume":"10","year":"2001","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C12","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1126\/science.292.5521.1552","article-title":"Impairment of the ubiquitin-proteasome system by protein aggregation","volume":"292","year":"2001","journal-title":"Science"},{"key":"key\n\t\t\t\t20171012173847_DDL135C13","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1073\/pnas.97.2.657","article-title":"Regulation of expanded polyglutamine protein aggregation and nuclear localization in glucocorticoid receptor","volume":"97","year":"2000","journal-title":"Proc. Natl Acad. Sci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C14","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1073\/pnas.97.6.2898","article-title":"Effects of heat shock, heat shock protein 40 (HDJ-2), and proteasome inhibition on protein aggregation in cellular models of Huntington's disease","volume":"97","year":"2000","journal-title":"Proc. Natl Acad. Sci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C15","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1083\/jcb.153.4.851","article-title":"Intracellular aggregation of polypeptides with expanded polyglutamine domain is stimulated by stress-activated kinase MEKK1","volume":"153","year":"2001","journal-title":"J. Cell Biol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S0092-8674(03)00349-0","article-title":"Interaction of Akt-phosphorylated ataxin-1 with 14-3-3 mediates neurodegeneration in spinocerebellar ataxia type 1","volume":"113","year":"2003","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171012173847_DDL135C17","first-page":"831","article-title":"The IGF-1\/Akt pathway is neuroprotective in Huntington's disease and involves Huntingtin phosphorylation by Akt","volume":"2","year":"2002","journal-title":"Cell"},{"key":"key\n\t\t\t\t20171012173847_DDL135C18","doi-asserted-by":"crossref","first-page":"16412","DOI":"10.1073\/pnas.182426899","article-title":"Molecular chaperones as modulators of polyglutamine protein aggregation and toxicity","volume":"99","year":"2002","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2202-6-1","article-title":"Reversal of a full-length mutant huntingtin neuronal cell phenotype by chemical inhibitors of polyglutamine-mediated aggregation","volume":"6","year":"2005","journal-title":"BMC Neurosci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C20","doi-asserted-by":"crossref","first-page":"6118","DOI":"10.1073\/pnas.95.11.6118","article-title":"Huntingtin aggregation monitored by dynamic light scattering","volume":"95","year":"1998","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C21","first-page":"437","article-title":"A screen for drugs that protect against the cytotoxicity of polyglutamine-expanded androgen receptor","volume":"13","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C22","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1073\/pnas.0408936102","article-title":"A potent small molecule inhibits polyglutamine aggregation in Huntington's disease neurons and suppresses neurodegeneration in vivo","volume":"102","year":"2005","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C23","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.nbd.2004.04.001","article-title":"A cell-based screen for drugs to treat Huntington's disease","volume":"16","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20171012173847_DDL135C24","doi-asserted-by":"crossref","first-page":"16400","DOI":"10.1073\/pnas.182426599","article-title":"Identification of benzothiazoles as potential polyglutamine aggregation inhibitors of Huntington's disease by using an automated filter retardation assay","volume":"99","year":"2002","journal-title":"Proc. Natl Acad. Sci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C25","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1093\/hmg\/ddi122","article-title":"A cell-based screen for modulators of ataxin-1 phosphorylation","volume":"14","year":"2005","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C26","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/35099568","article-title":"Histone deacetylase inhibitors arrest polyglutamine-dependent neurodegeneration in Drosophila","volume":"413","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012173847_DDL135C27","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1006\/nbdi.2001.0438","article-title":"Inhibition of polyglutamine aggregation in R6\/2 HD brain slices-complex dose-response profiles","volume":"8","year":"2001","journal-title":"Neurobiol. Dis."},{"key":"key\n\t\t\t\t20171012173847_DDL135C28","doi-asserted-by":"crossref","first-page":"6739","DOI":"10.1073\/pnas.110138997","article-title":"Inhibition of huntingtin fibrillogenesis by specific antibodies and small molecules: implications for Huntington's disease therapy","volume":"97","year":"2000","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C29","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/S0306-4522(01)00017-3","article-title":"Creatine-supplemented diet extends Purkinje cell survival in spinocerebellar ataxia type 1 transgenic mice but does not prevent the ataxic phenotype","volume":"103","year":"2001","journal-title":"Neuroscience"},{"key":"key\n\t\t\t\t20171012173847_DDL135C30","doi-asserted-by":"crossref","first-page":"19831","DOI":"10.1074\/jbc.M001475200","article-title":"Inhibiting caspase cleavage of huntingtin reduces toxicity and aggregate formation in neuronal and non-neuronal cells","volume":"275","year":"2000","journal-title":"J. Biol. Chem."},{"key":"key\n\t\t\t\t20171012173847_DDL135C31","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0304-3940(03)00657-8","article-title":"Oxidative stimuli affect polyglutamine aggregation and cell death in human mutant ataxin-1-expressing cells","volume":"348","year":"2003","journal-title":"Neurosci. Lett."},{"key":"key\n\t\t\t\t20171012173847_DDL135C32","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.mcn.2003.11.014","article-title":"Potentiation of NMDA receptor-mediated excitotoxicity linked with intrinsic apoptotic pathway in YAC transgenic mouse model of Huntington's disease","volume":"25","year":"2004","journal-title":"Mol. Cell. Neurosci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C33","first-page":"204","article-title":"Inhibition of caspase-1 slows disease progression in a mouse model of Huntington's disease","volume":"399","year":"1999","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012173847_DDL135C34","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","year":"2003","journal-title":"Proc. Natl Acad. Sci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C35","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0896-6273(03)00697-4","article-title":"A rapid cellular FRET assay of polyglutamine aggregation identifies a novel inhibitor","volume":"40","year":"2003","journal-title":"Neuron"},{"key":"key\n\t\t\t\t20171012173847_DDL135C36","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1038\/ncb863","article-title":"Polyglutamine protein aggregates are dynamic","volume":"4","year":"2002","journal-title":"Nat. Cell Biol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0014-4827(02)00098-8","article-title":"Epidermal growth factor receptor: mechanisms of activation and signalling","volume":"284","year":"2003","journal-title":"Exp. Cell. Res."},{"key":"key\n\t\t\t\t20171012173847_DDL135C38","first-page":"3639","article-title":"Distribution and function of EGFR in human tissue and the effect of EGFR tyrosine kinase inhibition","volume":"23","year":"2003","journal-title":"Anticancer Res."},{"key":"key\n\t\t\t\t20171012173847_DDL135C39","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/j.1875-9114.1987.tb03503.x","article-title":"Molsidomine: alternative approaches to treat myocardial ischemia","volume":"7","year":"1987","journal-title":"Pharmacotherapy"},{"key":"key\n\t\t\t\t20171012173847_DDL135C40","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1002\/jlb.66.5.712","article-title":"Modular components of phagocytosis","volume":"66","year":"1999","journal-title":"J. Leukoc. Biol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C41","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1182\/blood-2002-04-1251","article-title":"Regulation of Akt-dependent cell survival by Syk and Rac","volume":"101","year":"2003","journal-title":"Blood"},{"key":"key\n\t\t\t\t20171012173847_DDL135C42","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1016\/S0969-2126(01)00242-8","article-title":"Solution structure of the C-terminal SH2 domain of the human tyrosine kinase Syk complexed with a phosphotyrosine pentapeptide","volume":"3","year":"1995","journal-title":"Structure"},{"key":"key\n\t\t\t\t20171012173847_DDL135C43","doi-asserted-by":"crossref","first-page":"538","DOI":"10.4049\/jimmunol.166.1.538","article-title":"Protein-tyrosine kinase Syk expressed in human nasal fibroblasts and its effect on RANTES production","volume":"166","year":"2001","journal-title":"J. Immunol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C44","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1093\/hmg\/ddh131","article-title":"Sodium butyrate ameliorates phenotypic expression in a transgenic mouse model of spinal and bulbar muscular atrophy","volume":"13","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C45","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1073\/pnas.0437870100","article-title":"Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease","volume":"100","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C46","doi-asserted-by":"crossref","first-page":"9418","DOI":"10.1523\/JNEUROSCI.23-28-09418.2003","article-title":"Histone deacetylase inhibition by sodium butyrate chemotherapy ameliorates the neurodegenerative phenotype in Huntington's disease mice","volume":"23","year":"2003","journal-title":"J. Neurosci."},{"key":"key\n\t\t\t\t20171012173847_DDL135C47","first-page":"159","article-title":"Pseudopupil phenomena in the compound eye of Drosophila","volume":"9","year":"1971","journal-title":"Kybernetik"},{"key":"key\n\t\t\t\t20171012173847_DDL135C48","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1006\/jmbi.2001.4850","article-title":"Polyglutamine aggregation behavior in vitro supports a recruitment mechanism of cytotoxicity","volume":"311","year":"2001","journal-title":"J. Mol. Biol."},{"key":"key\n\t\t\t\t20171012173847_DDL135C49","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1096\/fj.03-1238fje","article-title":"Inhibition of polyglutamine aggregate cytotoxicity by a structure-based elongation inhibitor","volume":"18","year":"2004","journal-title":"FASEB J."},{"key":"key\n\t\t\t\t20171012173847_DDL135C50","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1093\/hmg\/11.23.2905","article-title":"Aggregated polyglutamine peptides delivered to nuclei are toxic to mammalian cells","volume":"11","year":"2002","journal-title":"Hum. Mol. Genet."},{"key":"key\n\t\t\t\t20171012173847_DDL135C51","doi-asserted-by":"crossref","first-page":"5950","DOI":"10.1073\/pnas.2628045100","article-title":"A cell-based assay for aggregation inhibitors as therapeutics of polyglutamine-repeat disease and validation in Drosophila","volume":"100","year":"2003","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"key\n\t\t\t\t20171012173847_DDL135C52","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nm0202-143","article-title":"Prolonged survival and decreased abnormal movements in transgenic model of Huntington disease, with administration of the transglutaminase inhibitor cystamine","volume":"8","year":"2002","journal-title":"Nat. Med."},{"key":"key\n\t\t\t\t20171012173847_DDL135C53","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nature01301","article-title":"Pivotal role of oligomerization in expanded polyglutamine neurodegenerative disorders","volume":"421","year":"2003","journal-title":"Nature"},{"key":"key\n\t\t\t\t20171012173847_DDL135C54","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00001622-200403000-00008","article-title":"The role of EGFR inhibitors in non-small cell lung cancer","volume":"16","year":"2004","journal-title":"Curr. Opin. Oncol."}],"container-title":["Human Molecular Genetics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/hmg\/article-pdf\/15\/13\/2114\/17242775\/ddl135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,4,19]],"date-time":"2019-04-19T00:18:14Z","timestamp":1555633094000},"score":1,"resource":{"primary":{"URL":"http:\/\/academic.oup.com\/hmg\/article\/15\/13\/2114\/2901073\/Biologically-active-molecules-that-reduce"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,5,23]]},"references-count":54,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2006,5,23]]},"published-print":{"date-parts":[[2006,7,1]]}},"URL":"https:\/\/doi.org\/10.1093\/hmg\/ddl135","relation":{},"ISSN":["0964-6906","1460-2083"],"issn-type":[{"value":"0964-6906","type":"print"},{"value":"1460-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2006,5,23]]}}}